Monday, October 20, 2025 from 1:45 p.m. to 5:00 p.m. CDT at Regency Room, 2nd Floor
This session is being recorded.
Learn MoreThe Clinical Reasoning Series aims to deliver programs that will meaningfully contribute to advancing pharmacy specialists’ knowledge, skills, and clinical judgment. Topic selection for the program reflects content that is timely and of relevance and value to the practice of Board Pharmacotherapy Specialists (BCPS).
Participants will have the opportunity to attend four educational activities, broken into a two-part morning and a one-part afternoon session. Part Two will offer 3.0 contact hours of continuing pharmacy education credit toward BCPS recertification credit upon completing the required posttests by the submission deadline and achieving a predetermined passing score. The posttests will be available on November 12, 2025. The deadline to submit posttests and earn recertification credit for the session will be November 12, 2026. If you have not already purchased posttest access and wish to add it to your registration, email [email protected] or visit the registration desk on or before October 21, 2025.
 | | Moderator: | Alyssa Robertson, Pharm.D., BCEMP, BCPS | | Clinical Pharmacist Specialist - Emergency Medicine
WellSpan York Hospital
York, PA | | View Biography |
|
Managing Risk: Transitions in Antithrombotic Therapy and Lipid Medication Management1:45 p.m. to 5:00 p.m.
Available for 3.00 hours of CPE credit
Activity Number: 0217-0000-25-110-L01-P
Activity Type: An Application-Based Activity
Managing Risk: Transitions in Antithrombotic Therapy and Lipid Medication Management will provide an overview of how to approach peri-procedural antithrombotic medication therapy, as well as how to determine the most appropriate patient-specific therapeutic monitoring plan throughout various stages of patient care. This session will also provide updates to lipid management by highlighting new risk assessment tools and biomarkers, providing guidance on when statin therapy may or may not be appropriate, and addressing novel lipid-lowering therapies in the pipeline. Presentation titles are: What A Thrill! Launching Into Peri-ACS Antithrombotic Therapies and Catching the Wave of Integrated Care: Predictive Models and Emerging Therapies in Cardiovascular Risk Management. The dual presentation will include guidance for medication therapy modifications, diagnosis-related considerations, therapeutic monitoring, and application of gained knowledge to patient case studies. Presenters will participate in a Q&A panel. This activity offers 3.0 contact hours of CPE and/or BCPS recertification credit.
There will be a break in programming from 3:00-3:15 p.m. Learning Objectives1. Distinguish between available antiplatelet medication options for the treatment of acute coronary syndromes. 2. Evaluate upstream antiplatelet administration timing as a dosing strategy for NSTE-ACS. 3. Apply ischemic and bleeding risk scoring tools to inform dosing strategies. 4. Choose the best dosing strategies for individual patient care scenarios. 5. Identify comprehensive care plans that integrate cardiovascular, kidney, and metabolic targets for patients with complex conditions using recommendations from the American Heart Association's Presidential Advisory. 6. Identify key factors influencing the predictive accuracy of the pooled cohort equations vs. the PREVENT model in predicting cardiovascular risk in select populations. 7. Determine how global coronary artery calcium guidelines can be applied in clinical practice to improve patient outcomes. 8. Evaluate emerging therapeutic strategies targeting Lipoprotein(a) and their potential impact on reducing cardiovascular events in high-risk patients.  | | Speaker: | Amanda G. Sowder, Pharm.D., BCCP | | Interventional Cardiology & Electrophysiology Laboratory Pharmacist
Adventhealth Orlando | | View Biography |
|  | | Speaker: | Maria C. Coyle, Pharm.D., B.S.Pharm, FCCP, BCACP, BCPS, CLS | | Professor – Clinical
The Ohio State University College of Pharmacy
Specialty Pharmacist - Ambulatory
The Ohio State University Wexner Medical Center
Columbus, Ohio
| | View Biography |
|
|